FDA Approves Shield: A Breakthrough Blood Test for Colon Cancer Detection
The FDA has approved a new blood test called Shield, developed by Guardant Health, Inc., for the early detection of colorectal cancer. This innovative test is designed to identify colorectal cancer-related alterations in cell-free DNA (cfDNA) from a blood sample, offering a less invasive alternative to traditional diagnostic methods. What is Shield? Shield is a…